Negative correlation was found between VAT LPL levels and blood markers of liver injury, such as transaminases (aspartate aminotransferase (AST): r = − 0.23, p = 0.045; alanine aminotransferase (ALT): r = −0.36, p= 0.001), and gamma-glutamyl transpeptidase (GGT): r = −0.22, p = 0.045), regardless of NAFLD, which was diagnosed in 75% of participants undergoing liver biopsy (Table 2, column B). The gene discussed is GGTLC1; the disease is metabolic dysfunction-associated steatotic liver disease.